# Robert Kopple > Robert Kopple is a convertible note investor at Kopple, Klinger & Elbaz backing FinTech. See 3 investments, check sizes, portfolio. Updated Aug 2026. - Type: Angel Investor - Fund: [Kopple, Klinger & Elbaz](https://shizune.co/investors/profile/kopple-klinger-elbaz) - Location: Los Angeles, United States - Total investments: 3 - Last investment: Sep 2024 - Lead investor: 33% - Last updated: Aug 2026 Robert Kopple is a convertible note investor at Kopple, Klinger & Elbaz in Los Angeles focused on FinTech and Finance. Robert C. Kopple is based out of Vancouver, Ontario, and is the Partner of Kopple, Klinger & Elbaz. Robert previously worked at Gelum Resources as a Board of Directors. Robert C. Kopple attended New York University. ## Round sizes | Stage | Round size | | --- | --- | | Venture - Series Unknown | $3.3M–$4.8M | ## Investment focus ### Industry | Industry | Investments | Share | | --- | --- | --- | | FinTech | 1 | 33% | | Finance | 1 | 33% | | Life Science | 1 | 33% | | Biotechnology | 1 | 33% | | Financial Services | 1 | 33% | ### Stage | Stage | Investments | Share | | --- | --- | --- | | Convertible Note | 1 | 33% | | Venture - Series Unknown | 1 | 33% | ### Country | Country | Investments | Share | | --- | --- | --- | | United States | 1 | 33% | | United Kingdom | 1 | 33% | ## Investments | Company | Description | Amount | Stage | Date | Website | | --- | --- | --- | --- | --- | --- | | ILC Therapeutics | ILC Therapeutics Ltd is an early-stage biotechnology company focused on modulating the Innate Immune System through the development of novel peptide therapeutics for the treatment of Covid-19, Cancer, Atopic Dermatitis, and Psoriasis. | $3.3M | Venture - Series Unknown | Sep 11, 2024 | | | ILC Therapeutics | ILC Therapeutics Ltd is an early-stage biotechnology company focused on modulating the Innate Immune System through the development of novel peptide therapeutics for the treatment of Covid-19, Cancer, Atopic Dermatitis, and Psoriasis. | $4.8M | Venture - Series Unknown | Sep 06, 2021 | | | Tradier | Tradier is a financial services cloud provider that offers a groundbreaking solution to serve platform providers, developers and investors. The Tradier solution features an innovative set of fully hosted APIs, modules, and "out of the box" tools that are leveraged by a growing list of providers. | $3M | Convertible Note | Oct 15, 2016 | | 3 of 3 investments shown. ## Co-investors - [EOS Technology Investment Syndicate](https://shizune.co/investors/profile/eos-technology-investment-syndicate) — VC Fund, 2 deals together - [Scottish Enterprise](https://shizune.co/investors/profile/scottish-enterprise) — VC Fund, 2 deals together - [Medical Incubator Japan](https://shizune.co/investors/profile/medical-incubator-japan) — VC Fund, 1 deal together ## About Kopple, Klinger & Elbaz VC Fund 1 contacts available at Kopple, Klinger & Elbaz. | Name | Title | Profile | | --- | --- | --- | | Robert Kopple | Partner | https://shizune.co/investors/profile/robert-kopple | ## Similar investors ### Similar industry - [SOSV](https://shizune.co/investors/profile/sosv) — VC Fund - [ARCH Venture Partners](https://shizune.co/investors/profile/arch-venture-partners) — VC Fund - [Alexandria Venture Investments](https://shizune.co/investors/profile/alexandria-venture-investments) — VC Fund ### Similar stage - [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund - [SOSV](https://shizune.co/investors/profile/sosv) — VC Fund - [Innova Memphis](https://shizune.co/investors/profile/innova-memphis) — VC Fund ### Similar country - [Bpifrance](https://shizune.co/investors/profile/bpifrance) — VC Fund - [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund - [SFC Capital](https://shizune.co/investors/profile/startup-funding-club) — VC Fund ## Featured in investor lists - [Life Science Angel Investors in United Kingdom](https://shizune.co/investors/life-science-angel-investors-united-kingdom) - [Life Science Angel Investors](https://shizune.co/investors/life-science-angel-investors) - [Life Science Angel Investors in Europe](https://shizune.co/investors/life-science-angel-investors-europe) - [Biotechnology Angel Investors in United Kingdom](https://shizune.co/investors/biotechnology-angel-investors-united-kingdom) - [Biotech Angel Investors in United Kingdom](https://shizune.co/investors/biotech-angel-investors-united-kingdom) - [Biotechnology Angel Investors in Europe](https://shizune.co/investors/biotechnology-angel-investors-europe) ## FAQ ### What does Robert Kopple invest in? Robert Kopple invests primarily in FinTech, Finance and Life Science startups, most often at Convertible Note and Venture - Series Unknown stage. Most of the 3 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio. ### What is Robert Kopple's check size? Robert Kopple typically joins rounds of $3.3M–$4.8M at Venture - Series Unknown. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Robert Kopple participates in. ### When did Robert Kopple last invest? The most recent investment recorded for Robert Kopple closed in Sep 2024. Shizune tracks 3 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly. ### Is Shizune's investor data accurate? Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page. # About Shizune Shizune.co is an investor database. Core features: - 48,091 startup investors (angels, VCs, accelerators, and others) - Email, phone, LinkedIn (for intros), socials, and other contact data - Updated daily from public funding news - CSV and Excel export The User can access the full database FOR FREE after signing up: shizune.co